In addition, Western blotting analysis of the tumor samples showed that lomerizine 2HCl can significantly downregulate the PI3K/AKT/mTOR signaling pathway in HT‐29 xenografts (Figure 6E). The gene discussed is MTOR; the disease is neoplasm.